DE102005033630A1 - Calcium-Peptid-Komponente - Google Patents

Calcium-Peptid-Komponente Download PDF

Info

Publication number: DE102005033630A1
Authority: DE; Germany
Prior art keywords: calcium; peptide component; preparation; glycomacropeptide; added
Prior art date: 2005-07-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

DE102005033630A

Other languages

German (de)

English (en)

Inventor

Marco Dr. Sell

Dirk Dr. Bode

Günther Dr. Sawatzki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

HUMANA MILCHUNION EG, 48351 EVERSWINKEL, DE

Original Assignee

HUMANA GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-19

Filing date

2005-07-19

Publication date

2007-01-25

2005-07-19 Application filed by HUMANA GmbH filed Critical HUMANA GmbH

2005-07-19 Priority to DE102005033630A priority Critical patent/DE102005033630A1/de

2006-05-31 Priority to EP06754001A priority patent/EP1903895A2/de

2006-05-31 Priority to EA200800205A priority patent/EA016259B1/ru

2006-05-31 Priority to PCT/EP2006/005173 priority patent/WO2007009529A2/de

2006-05-31 Priority to UAA200801548A priority patent/UA94716C2/uk

2007-01-25 Publication of DE102005033630A1 publication Critical patent/DE102005033630A1/de

Status Withdrawn legal-status Critical Current

Links

OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 35
239000011575 calcium Substances 0.000 claims abstract description 35
229910052791 calcium Inorganic materials 0.000 claims abstract description 35
108010067454 caseinomacropeptide Proteins 0.000 claims abstract description 13
159000000007 calcium salts Chemical class 0.000 claims abstract description 10
229960005069 calcium Drugs 0.000 claims description 33
238000002360 preparation method Methods 0.000 claims description 9
235000013305 food Nutrition 0.000 claims description 7
238000010521 absorption reaction Methods 0.000 claims description 5
239000003795 chemical substances by application Substances 0.000 claims description 5
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
206010036618 Premenstrual syndrome Diseases 0.000 claims description 4
230000036772 blood pressure Effects 0.000 claims description 3
FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 3
235000015872 dietary supplement Nutrition 0.000 claims description 3
230000001105 regulatory effect Effects 0.000 claims description 3
208000024891 symptom Diseases 0.000 claims description 3
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
239000001736 Calcium glycerylphosphate Substances 0.000 claims description 2
229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
235000010216 calcium carbonate Nutrition 0.000 claims description 2
239000001110 calcium chloride Substances 0.000 claims description 2
229910001628 calcium chloride Inorganic materials 0.000 claims description 2
235000011148 calcium chloride Nutrition 0.000 claims description 2
239000001354 calcium citrate Substances 0.000 claims description 2
235000011001 calcium citrates Nutrition 0.000 claims description 2
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 2
239000004227 calcium gluconate Substances 0.000 claims description 2
235000013927 calcium gluconate Nutrition 0.000 claims description 2
229960004494 calcium gluconate Drugs 0.000 claims description 2
229940095618 calcium glycerophosphate Drugs 0.000 claims description 2
UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims description 2
235000019299 calcium glycerylphosphate Nutrition 0.000 claims description 2
239000000920 calcium hydroxide Substances 0.000 claims description 2
229910001861 calcium hydroxide Inorganic materials 0.000 claims description 2
MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
239000001527 calcium lactate Substances 0.000 claims description 2
229960002401 calcium lactate Drugs 0.000 claims description 2
235000011086 calcium lactate Nutrition 0.000 claims description 2
BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 2
239000000292 calcium oxide Substances 0.000 claims description 2
ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 2
NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
239000003814 drug Substances 0.000 claims description 2
239000000835 fiber Substances 0.000 claims description 2
235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
239000011707 mineral Substances 0.000 claims description 2
235000010755 mineral Nutrition 0.000 claims description 2
239000000825 pharmaceutical preparation Substances 0.000 claims description 2
229940068065 phytosterols Drugs 0.000 claims description 2
239000011573 trace mineral Substances 0.000 claims description 2
235000013619 trace mineral Nutrition 0.000 claims description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
229940088594 vitamin Drugs 0.000 claims description 2
239000011782 vitamin Substances 0.000 claims description 2
229930003231 vitamin Natural products 0.000 claims description 2
235000013343 vitamin Nutrition 0.000 claims description 2
239000000654 additive Substances 0.000 claims 1
230000037396 body weight Effects 0.000 claims 1
230000004580 weight loss Effects 0.000 claims 1
235000013336 milk Nutrition 0.000 abstract description 7
239000008267 milk Substances 0.000 abstract description 7
210000004080 milk Anatomy 0.000 abstract description 7
102000004169 proteins and genes Human genes 0.000 abstract description 3
108090000623 proteins and genes Proteins 0.000 abstract description 3
108090000765 processed proteins & peptides Proteins 0.000 abstract description 2
235000001465 calcium Nutrition 0.000 description 32
108010076119 Caseins Proteins 0.000 description 9
102000011632 Caseins Human genes 0.000 description 9
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 8
235000021240 caseins Nutrition 0.000 description 8
230000000694 effects Effects 0.000 description 5
239000005018 casein Substances 0.000 description 4
229940021722 caseins Drugs 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
239000003925 fat Substances 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
239000000047 product Substances 0.000 description 3
239000013585 weight reducing agent Substances 0.000 description 3
206010006956 Calcium deficiency Diseases 0.000 description 2
102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
206010020772 Hypertension Diseases 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
208000001132 Osteoporosis Diseases 0.000 description 2
239000005862 Whey Substances 0.000 description 2
102000007544 Whey Proteins Human genes 0.000 description 2
108010046377 Whey Proteins Proteins 0.000 description 2
235000013351 cheese Nutrition 0.000 description 2
235000013365 dairy product Nutrition 0.000 description 2
201000010099 disease Diseases 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000000203 mixture Substances 0.000 description 2
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
238000004260 weight control Methods 0.000 description 2
206010001497 Agitation Diseases 0.000 description 1
208000019901 Anxiety disease Diseases 0.000 description 1
235000008733 Citrus aurantifolia Nutrition 0.000 description 1
208000036004 Cow milk intolerance Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
208000001145 Metabolic Syndrome Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
102000014171 Milk Proteins Human genes 0.000 description 1
108010011756 Milk Proteins Proteins 0.000 description 1
208000019022 Mood disease Diseases 0.000 description 1
208000007101 Muscle Cramp Diseases 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
241000700159 Rattus Species 0.000 description 1
208000005392 Spasm Diseases 0.000 description 1
235000011941 Tilia x europaea Nutrition 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
230000036506 anxiety Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
230000006583 body weight regulation Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
230000037182 bone density Effects 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
235000011850 desserts Nutrition 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000002898 effect on depression Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
235000013373 food additive Nutrition 0.000 description 1
239000002778 food additive Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
235000008410 fruit bars Nutrition 0.000 description 1
235000015203 fruit juice Nutrition 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
235000015243 ice cream Nutrition 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000004571 lime Substances 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
235000021239 milk protein Nutrition 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
235000016046 other dairy product Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000029865 regulation of blood pressure Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000013049 sediment Substances 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
239000000344 soap Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
230000004584 weight gain Effects 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1
235000021246 κ-casein Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Inorganic Chemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Cardiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

DE102005033630A 2005-07-19 2005-07-19 Calcium-Peptid-Komponente Withdrawn DE102005033630A1 (de)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
DE102005033630A DE102005033630A1 (de)	2005-07-19	2005-07-19	Calcium-Peptid-Komponente
EP06754001A EP1903895A2 (de)	2005-07-19	2006-05-31	Calcium-peptid-komponente
EA200800205A EA016259B1 (ru)	2005-07-19	2006-05-31	Применение кальций-пептидного компонента для снижения веса тела
PCT/EP2006/005173 WO2007009529A2 (de)	2005-07-19	2006-05-31	Calcium-peptid-komponente
UAA200801548A UA94716C2 (uk)	2005-07-19	2006-05-31	Кальцієпептидний компонент для зниження ваги тіла

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102005033630A DE102005033630A1 (de)	2005-07-19	2005-07-19	Calcium-Peptid-Komponente

Publications (1)

Publication Number	Publication Date
DE102005033630A1 true DE102005033630A1 (de)	2007-01-25

Family

ID=37575596

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE102005033630A Withdrawn DE102005033630A1 (de)	2005-07-19	2005-07-19	Calcium-Peptid-Komponente

Country Status (5)

Country	Link
EP (1)	EP1903895A2 (uk)
DE (1)	DE102005033630A1 (uk)
EA (1)	EA016259B1 (uk)
UA (1)	UA94716C2 (uk)
WO (1)	WO2007009529A2 (uk)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007022694A1 (de)	2007-05-11	2008-11-13	Humana Milchunion Eg	Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080126195A1 (en)	2004-07-22	2008-05-29	Ritter Andrew J	Methods and Compositions for Treating Lactose Intolerance
DE102006052560B4 (de) *	2006-11-06	2010-01-21	Humana Milchunion Eg	Anti-diabetogene Calcium-Peptid-Zusammensetzung
AU2010218439B2 (en)	2009-02-24	2016-10-20	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
EP3202406A1 (en)	2010-04-28	2017-08-09	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
CN103445045A (zh) *	2012-05-30	2013-12-18	孔徐生	一种具有促进钙吸收功能的组合物及其制备方法
CN109805417A (zh) *	2019-03-01	2019-05-28	河南九九一生物科技有限公司	一种能够增加骨密度的保健食品及其加工方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001037850A2 (en) *	1999-11-22	2001-05-31	Societe Des Produits Nestle S.A.	Use of a milk protein hydrolysate in the treatment of diabetes
US6384087B1 (en) *	2000-09-01	2002-05-07	University Of Tennesseee Research Corporation, Inc.	Materials and methods for the treatment or prevention of obesity
WO2002052954A2 (en) *	2001-01-08	2002-07-11	Societe Des Produits Nestle S.A.	Nutritional composition for a bone condition
US20030161863A1 (en) *	2000-04-18	2003-08-28	Olivier Ballevre	Nutritional modules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3373544B2 (ja) *	1991-12-05	2003-02-04	明治乳業株式会社	月経困難症を緩和する効果のある、カルシウム利用性に優れた飲食品及び医薬品
US20030165574A1 (en) *	2002-03-01	2003-09-04	Ward Loren Spencer	Compositions and methods for treatment of body weight conditions
JP2003048843A (ja) *	2002-07-17	2003-02-21	Meiji Milk Prod Co Ltd	月経困難症の予防及び／又は治療用機能性食品

2005
- 2005-07-19 DE DE102005033630A patent/DE102005033630A1/de not_active Withdrawn
2006
- 2006-05-31 EP EP06754001A patent/EP1903895A2/de not_active Withdrawn
- 2006-05-31 WO PCT/EP2006/005173 patent/WO2007009529A2/de not_active Ceased
- 2006-05-31 EA EA200800205A patent/EA016259B1/ru not_active IP Right Cessation
- 2006-05-31 UA UAA200801548A patent/UA94716C2/uk unknown

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001037850A2 (en) *	1999-11-22	2001-05-31	Societe Des Produits Nestle S.A.	Use of a milk protein hydrolysate in the treatment of diabetes
US20030161863A1 (en) *	2000-04-18	2003-08-28	Olivier Ballevre	Nutritional modules
US6384087B1 (en) *	2000-09-01	2002-05-07	University Of Tennesseee Research Corporation, Inc.	Materials and methods for the treatment or prevention of obesity
WO2002052954A2 (en) *	2001-01-08	2002-07-11	Societe Des Produits Nestle S.A.	Nutritional composition for a bone condition

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BERTONE-JOHNSON,E.R.,et.al.:Calsium and Vitamin D Intake and Risk of Incident Premenstrual Syndrome.In:Arch.Intern.Med., Vol.165,2005,S.1246-1252 *
BERTONE-JOHNSON,E.R.,et.al.:Calsium and Vitamin D Intake and Risk of Incident Premenstrual Syndrome.In:Arch.Intern.Med., Vol.165,2005,S.1246-1252;
ETCHEVERRY,P.,et.al.:The Effect of Calcium Salts, Ascorbic Acid and Peptic Ph on Calcium, Zinc and Iron Bioavailabilities from Fortified Human Milk.In: International Journal For Vitamin And Nutrition Research, 2005,Vol.75,S.171-178 *
ETCHEVERRY,P.,et.al.:The Effect of Calcium Salts, Ascorbic Acid and Peptic Ph on Calcium, Zinc and Iron Bioavailabilities from Fortified Human Milk.In: International Journal For Vitamin And Nutrition Research, 2005,Vol.75,S.171-178;
JORDE,R.,et.al.:Calcium from dairy products, vitamin D intake, and blood pressure:the Tromso study·1,2,3¶.In:American Journal of Clinical Nutrition, Vol.71,No.6, 2000,S.1530-1535 *
JORDE,R.,et.al.:Calcium from dairy products, vitamin D intake, and blood pressure:the Tromso study1,2,3.In:American Journal of Clinical Nutrition, Vol.71,No.6, 2000,S.1530-1535;

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007022694A1 (de)	2007-05-11	2008-11-13	Humana Milchunion Eg	Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme

Also Published As

Publication number	Publication date
WO2007009529A3 (de)	2007-06-28
EP1903895A2 (de)	2008-04-02
EA200800205A1 (ru)	2008-08-29
WO2007009529A2 (de)	2007-01-25
EA016259B1 (ru)	2012-03-30
UA94716C2 (uk)	2011-06-10

Publication	Publication Date	Title
DE69233250T2 (de)	2004-08-26	Kombinationen aus calzium und vitamin d
DE60310934T2 (de)	2007-10-11	Zusammensetzung, die ein sättigungsgefühl hervorruft
DE69110130T2 (de)	1995-11-02	Zusätze aus calcium und spurenelementen.
US6468962B1 (en)	2002-10-22	Nutritional intervention composition for enhancing and extending satiety
DE69732871T2 (de)	2006-04-06	Basisches Protein Zusammensetzung, basisches Peptid Zusammensetzung und deren Verwendung
EP2680713B1 (de)	2017-12-20	Zusammensetzung für ernährungszwecke
CN111616232A (zh)	2020-09-04	一种促进骨骼生长的儿童奶粉及其制备方法
DE60005104T2 (de)	2004-08-19	Diätzusatz aus fermentierte milchprodukte zur prävention von östeoporose
WO2008138821A1 (de)	2008-11-20	Milchfett-milchprotein-zusammensetzung (vorzugsweise verestert mit palmitinsäure) zur verbesserung der calcium-aufnahme
DE69922409T2 (de)	2005-05-19	Verwendung von natürlichen antisekretorischen Proteinen
DE102005033630A1 (de)	2007-01-25	Calcium-Peptid-Komponente
DE602006000511T2 (de)	2009-01-29	Dermatologische verwendung von proteinen aus milch
DE10008279A1 (de)	2001-08-30	Milchzucker enthaltende Zusammensetzung
WO2005097146A2 (en)	2005-10-20	Dairy components effective for fat loss
DE20300380U1 (de)	2003-03-13	Speiseeis
DE2845570C2 (de)	1985-10-17	Honig enthaltende Zusammensetzung
DE19534602C2 (de)	1999-09-09	Verwendung von Threonin zur Behandlung der Phenylketonurie
AT10252U1 (de)	2008-12-15	Eiweisspräparat
DE602004010182T2 (de)	2008-10-02	Mit calcium angereichertes getränk auf proteingrundlage, das calcium(lactat)gluconatcitrat enthält
NL9401958A (nl)	1996-07-01	Met eierschalenmeel verrijkt melkprodukt.
EP0374935B1 (de)	1993-06-30	Präparat zum Vorbeugen gegen Knochenschwund und zur Behandlung von Knochenschwund
DE102006052560B4 (de)	2010-01-21	Anti-diabetogene Calcium-Peptid-Zusammensetzung
WO2005074709A2 (de)	2005-08-18	Kalzium-angereicherte lebensmittel
US20070128252A1 (en)	2007-06-07	Compositions and methods for treatment of body weight conditions
DE2054769A1 (de)	1971-05-13	Diatetische Teigware

Legal Events

Date	Code	Title	Description
2007-01-25	OM8	Search report available as to paragraph 43 lit. 1 sentence 1 patent law
2008-05-15	8127	New person/name/address of the applicant	Owner name: HUMANA MILCHUNION EG, 48351 EVERSWINKEL, DE
2011-07-14	R012	Request for examination validly filed	Effective date: 20110423
2015-02-03	R119	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee
2015-04-30	R119	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee	Effective date: 20150203

DE102005033630A1 - Calcium-Peptid-Komponente - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (5)

Applications Claiming Priority (1)

Publications (1)

Family

ID=37575596

Family Applications (1)

Country Status (5)

Cited By (1)

Families Citing this family (6)

Citations (4)

Family Cites Families (3)

Patent Citations (4)

Non-Patent Citations (6)

Cited By (1)

Also Published As

Similar Documents

Legal Events